Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Dimopoulos

Showing results (211-220 of 288) with videos related to

Pageof 29
Sort By:
Blood|September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosisA H Sarris, R Luthra, V Papadimitracopoulou, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy: A Case Study in a Clinical Trial in Multiple MyelomaP Thilakarathne, A Palumbo, J Diels, et al.
BMC Urology|June 4, 2020
Axitinib as a third or further line of treatment in renal cancer: a single institution experienceG Tsironis, M Liontos, A Kyriazoglou, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2011
Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factorA Bamias, M Sotiropoulou, F Zagouri, et al.
Blood Cancer Journal|May 28, 2016
Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatmentE Terpos, M Migkou, D Christoulas, et al.
Leukemia|April 30, 2010
Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agentsL A Moulopoulos, M A Dimopoulos, D Christoulas, et al.
Oncology|September 20, 2002
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trialsC Bacoyiannis, M A Dimopoulos, H P Kalofonos, et al.
American Journal of Hematology|June 1, 1994
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiationM A Dimopoulos, J C Yau, S D Huan, et al.
Bone Marrow Transplantation|November 21, 2007
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trialC Papadimitriou, U Dafni, A Anagnostopoulos, et al.
European Journal of Haematology|November 1, 1991
Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantationJ C Yau, M A Dimopoulos, S D Huan, et al.
Pageof 29

Showing results (211-220 of 288) with videos related to

Sort By:
Pageof 29
Blood|September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosisA H Sarris, R Luthra, V Papadimitracopoulou, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy: A Case Study in a Clinical Trial in Multiple MyelomaP Thilakarathne, A Palumbo, J Diels, et al.
BMC Urology|June 4, 2020
Axitinib as a third or further line of treatment in renal cancer: a single institution experienceG Tsironis, M Liontos, A Kyriazoglou, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2011
Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factorA Bamias, M Sotiropoulou, F Zagouri, et al.
Blood Cancer Journal|May 28, 2016
Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatmentE Terpos, M Migkou, D Christoulas, et al.
Leukemia|April 30, 2010
Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agentsL A Moulopoulos, M A Dimopoulos, D Christoulas, et al.
Oncology|September 20, 2002
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trialsC Bacoyiannis, M A Dimopoulos, H P Kalofonos, et al.
American Journal of Hematology|June 1, 1994
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiationM A Dimopoulos, J C Yau, S D Huan, et al.
Bone Marrow Transplantation|November 21, 2007
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trialC Papadimitriou, U Dafni, A Anagnostopoulos, et al.
European Journal of Haematology|November 1, 1991
Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantationJ C Yau, M A Dimopoulos, S D Huan, et al.
Pageof 29